R01 CA127433/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2008	1
2009	3
2010	4
2011	6
2012	5
2013	3
2014	4
2015	2
2016	2
2021	1
2024	0

1

Signal transduction inhibitor therapy for lymphoma.

Witzig TE, Gupta M. Witzig TE, et al. Hematology Am Soc Hematol Educ Program. 2010;2010:265-70. doi: 10.1182/asheducation-2010.1.265. Hematology Am Soc Hematol Educ Program. 2010. PMID: 21239804 Free PMC article. Review.

2

MCIR1: A patient-derived mantle cell lymphoma line for discovering new treatments for ibrutinib resistance.

Wu X, Nowakowski KE, Abeykoon JP, Manske M, Stenson MJ, Timm MM, Hanson CA, Van Dyke DL, Dasari S, Witzig TE. Wu X, et al. Eur J Haematol. 2021 Oct;107(4):458-465. doi: 10.1111/ejh.13682. Epub 2021 Jul 18. Eur J Haematol. 2021. PMID: 34214199 Free PMC article.

3

Dual mTORC1/mTORC2 inhibition diminishes Akt activation and induces Puma-dependent apoptosis in lymphoid malignancies.

Gupta M, Hendrickson AE, Yun SS, Han JJ, Schneider PA, Koh BD, Stenson MJ, Wellik LE, Shing JC, Peterson KL, Flatten KS, Hess AD, Smith BD, Karp JE, Barr S, Witzig TE, Kaufmann SH. Gupta M, et al. Blood. 2012 Jan 12;119(2):476-87. doi: 10.1182/blood-2011-04-346601. Epub 2011 Nov 11. Blood. 2012. PMID: 22080480 Free PMC article.

4

Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphoma.

Gupta M, Stenson M, O'Byrne M, Maurer MJ, Habermann T, Cerhan JR, Weiner GW, Witzig TE. Gupta M, et al. Ann Oncol. 2016 Jan;27(1):165-72. doi: 10.1093/annonc/mdv486. Epub 2015 Oct 20. Ann Oncol. 2016. PMID: 26487586 Free PMC article.

5

Elevated serum IL-10 levels in diffuse large B-cell lymphoma: a mechanism of aberrant JAK2 activation.

Gupta M, Han JJ, Stenson M, Maurer M, Wellik L, Hu G, Ziesmer S, Dogan A, Witzig TE. Gupta M, et al. Blood. 2012 Mar 22;119(12):2844-53. doi: 10.1182/blood-2011-10-388538. Epub 2012 Feb 8. Blood. 2012. PMID: 22323454 Free PMC article.

6

Elevated soluble IL-2Rα, IL-8, and MIP-1β levels are associated with inferior outcome and are independent of MIPI score in patients with mantle cell lymphoma.

Sonbol MB, Maurer MJ, Stenson MJ, Allmer C, LaPlant BR, Weiner GJ, Macon WR, Cerhan JR, Witzig TE, Gupta M. Sonbol MB, et al. Am J Hematol. 2014 Dec;89(12):E223-7. doi: 10.1002/ajh.23838. Epub 2014 Sep 19. Am J Hematol. 2014. PMID: 25164110 Free PMC article.

7

Sorafenib, a multikinase inhibitor, is effective in vitro against non-Hodgkin lymphoma and synergizes with the mTOR inhibitor rapamycin.

Ramakrishnan V, Timm M, Haug JL, Kimlinger TK, Halling T, Wellik LE, Witzig TE, Rajkumar SV, Adjei AA, Kumar S. Ramakrishnan V, et al. Am J Hematol. 2012 Mar;87(3):277-83. doi: 10.1002/ajh.22263. Epub 2011 Dec 21. Am J Hematol. 2012. PMID: 22190165 Free PMC article.

8

A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and 90 yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma.

Witzig TE, Wiseman GA, Maurer MJ, Habermann TM, Micallef IN, Nowakowski GS, Ansell SM, Colgan JP, Inwards DJ, Porrata LF, Link BK, Zent CS, Johnston PB, Shanafelt TD, Allmer C, Asmann YW, Gupta M, Ballas ZK, Smith BJ, Weiner GJ. Witzig TE, et al. Am J Hematol. 2013 Jul;88(7):589-93. doi: 10.1002/ajh.23460. Epub 2013 Jun 12. Am J Hematol. 2013. PMID: 23619698 Free PMC article. Clinical Trial.

9

Cytotoxicity of farnesyltransferase inhibitors in lymphoid cells mediated by MAPK pathway inhibition and Bim up-regulation.

Ding H, Hackbarth J, Schneider PA, Peterson KL, Meng XW, Dai H, Witzig TE, Kaufmann SH. Ding H, et al. Blood. 2011 Nov 3;118(18):4872-81. doi: 10.1182/blood-2011-02-334870. Epub 2011 Jun 14. Blood. 2011. PMID: 21673341 Free PMC article.

10

A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma.

Witzig TE, Reeder CB, LaPlant BR, Gupta M, Johnston PB, Micallef IN, Porrata LF, Ansell SM, Colgan JP, Jacobsen ED, Ghobrial IM, Habermann TM. Witzig TE, et al. Leukemia. 2011 Feb;25(2):341-7. doi: 10.1038/leu.2010.226. Epub 2010 Dec 7. Leukemia. 2011. PMID: 21135857 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

23 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year